|
ERI1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.35899999978528E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.600550E-04 |
| Normal-vs-Stage2 |
2.686100E-02 |
| Normal-vs-Stage3 |
2.695400E-03 |
| Normal-vs-Stage4 |
1.762130E-02 |
| Stage1-vs-Stage2 |
2.693600E-01 |
| Stage1-vs-Stage3 |
8.226100E-02 |
| Stage1-vs-Stage4 |
9.764400E-01 |
| Stage2-vs-Stage3 |
7.643400E-01 |
| Stage2-vs-Stage4 |
3.330600E-01 |
| Stage3-vs-Stage4 |
1.413550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.05189999999311E-06 |
| Normal-vs-AfricanAmerican |
1.004210E-03 |
| Normal-vs-Asian |
7.235600E-01 |
| Caucasian-vs-AfricanAmerican |
9.699200E-01 |
| Caucasian-vs-Asian |
3.542200E-03 |
| AfricanAmerican-vs-Asian |
4.457400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.05839999999347E-05 |
| Normal-vs-Female |
1.82140000004605E-06 |
| Male-vs-Female |
1.976230E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.552400E-02 |
| Normal-vs-Extreme_Weight |
7.633500E-04 |
| Normal-vs-Obese |
1.98492999999855E-05 |
| Normal-vs-Extreme_Obese |
3.044400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.943600E-01 |
| Normal_Weight-vs-Obese |
9.737500E-03 |
| Normal_Weight-vs-Extreme_Obese |
8.588000E-01 |
| Extreme_Weight-vs-Obese |
1.402120E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.097000E-01 |
| Obese-vs-Extreme_Obese |
1.763950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.044100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.78440000553337E-08 |
| Normal-vs-Age(61-80Yrs) |
8.155000E-04 |
| Normal-vs-Age(81-100Yrs) |
4.800800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.956400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.628400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.078100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.580100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.040600E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.728500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.65919999994824E-06 |
| Normal-VS-Type2 PRCC |
2.058100E-02 |
| Normal-VS-KIRP CIMP |
2.541100E-03 |
| Normal-VS-Unclassified PRCC |
4.187400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.608200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.544400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.890800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.024000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.864500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.035770E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.771860E-02 |
| Normal-vs-N1 |
1.036900E-03 |
| Normal-vs-N2 |
1.776910E-03 |
| N0-vs-N1 |
2.003700E-02 |
| N0-vs-N2 |
4.040200E-01 |
| N1-vs-N2 |
5.837000E-01 |
|
|
